AboutVysioneer

Vysioneer is an oncology AI company. Our journey started from the belief that every tumor matters in curing cancer. Powered by our FDA-cleared AI platform, Vysioneer unlocks drug efficacy with lesion-level precision, empowering pharma and clinicians to find the right treatment for the right tumor at the right moment. Vysioneer is headquartered in Cambridge, MA.

Leadership

Jen-Tang (JT) Lu
Jen-Tang (JT) Lu, PhD

Advisors

Roger W. Ferguson, Jr.
Roger W. Ferguson, Jr., J.D., PhD
Business advisor
Former Vice Chairman, Federal Reserve
Joe Chang
Joe Chang, ScD
Business Advisor
Chief Strategy Officer, Appier
Christopher Ballesteros
Christopher Ballesteros
Business advisor
Chief Commercial Officer, KangarooHealth Inc.
Chih-Han Yu
Chih-Han Yu, PhD
Business Advisor
Co-founder and CEO, Appier
Lawrence Leighton
Lawrence Leighton, MBA
Business Advisor
Managing Director, Bentley Associates
Peter Steiger
Peter Steiger, PhD
Business Advisor
Chief Scientific Officer, CALYX
Erqi Pollom
Erqi Pollom, MD
Medical Advisor
Radiation Oncologist, Stanford Cancer Center
Raymond Y. Huang
Raymond Y. Huang, MD, PhD
Medical Advisor
Division Chief, Neuroradiology, Brigham and Women's Hospital
Jason Cheng
Jason Cheng, MD, PhD
Medical Advisor
Former Division Chief, Radiation Oncology, National Taiwan University Hospital
Ryan King
Ryan King, MD
Medical Advisor
Neuroradiologist, LCMC Health

Career

Join a team of world-leading experts passionate about making a global impact on cancer care through leading innovations built from scratch.

Full-Stack Software Engineer
Taipei, Taiwan, Full-Time
Lead, Life Sciences Partnerships
Cambridge, MA, Full-Time
Machine Learning Scientist
Taipei, Taiwan, Full-Time
PM and Quality Assurance/Regulatory Affairs
Taipei, Taiwan, Full-Time